Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure

doi:10.3748/wjg.v28.i28.3627

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 28

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8677)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

530

WORD

121

HTML

4451

Figures (1-2)

724

Sum=5826

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

375

Download

713

Sum=1088

Publishing Process of This Article

Item

Count

Browse

602

Download

1156

Sum=1758

Jul 28, 2022 (publication date) through Feb 17, 2026

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Gastroenterol. Jul 28, 2022; 28(28): 3627-3636
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3627

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure

Carl Randall Harrell, Dragica Pavlovic, Valentin Djonov, Vladislav Volarevic

Carl Randall Harrell, Regenerative Processing Plant LLC, Palm Harbor, FL 34176, United States

Dragica Pavlovic, Department of Genetics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac 34000, Serbia

Valentin Djonov, Institute of Anatomy, University of Bern, Bern 3012, Switzerland

Vladislav Volarevic, Department of Medical Genetics and Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac 34000, Serbia

Author contributions: Harrell CR, Djonov V and Volarevic V analyzed the data and wrote the manuscript; Pavlovic D designed and created figures and wrote the manuscript; All authors have read and approve the final manuscript.

Conflict-of-interest statement: Authors declare no conflict of interests for this article.

Corresponding author: Vladislav Volarevic, MD, Full Professor, Department of Medical Genetics and Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozara Markovica Street, Kragujevac 34000, Serbia. vladislav.volarevic@gmail.com

Received: March 24, 2022
Peer-review started: March 24, 2022
First decision: April 25, 2022
Revised: May 8, 2022
Accepted: June 24, 2022
Article in press: June 24, 2022
Published online: July 28, 2022
Processing time: 124 Days and 5.9 Hours

Core Tip

Core Tip: Due to their potent immunoregulatory, angiomodulatory and hepatoprotective properties, mesenchymal stem cells and their exosomes suppress detrimental immune response, prevent apoptosis and promote survival of injured hepatocytes which results in an enhanced repair and regeneration of acutely injured liver.